The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 10, 2007, Pages 1381-1389

  Herrmann, Markus ^a   Müller, Miriam ^a   Scharhag, Jürgen ^b   Sand Hill, Marga ^a   Kindermann, Wilfried ^b   Herrmann, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Acidosis; Bone turnover markers; Lactate

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1; GENE PRODUCT; LACTIC ACID; OSTEOCALCIN; PRO COLLAGEN TYPE I N TERMINAL PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANAEROBIC EXERCISE; ANAEROBIC THRESHOLD; ARTICLE; ATHLETE; BICYCLE ERGOMETER; BLOOD SAMPLING; BONE TURNOVER; CONTROLLED STUDY; ENDURANCE; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; FEMALE; HUMAN; IN VIVO STUDY; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MALE; MEASUREMENT; NORMAL HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ACID PHOSPHATASE; ACIDOSIS, LACTIC; ADULT; BIOLOGICAL MARKERS; BONE AND BONES; COLLAGEN TYPE I; EXERCISE; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOENZYMES; MALE; OSTEOCALCIN; PEPTIDE FRAGMENTS; PHYSICAL ENDURANCE; PROCOLLAGEN; TIME FACTORS;

EID: 35048817363     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.282     Document Type: Article

References (58)

1. Bennell KL, Malcolm SA, Thomas SA, Reid SJ, Brukner PD, Ebeling PR, et al. Risk factors for stress fractures in track and field athletes. A twelve-month prospective study. Am J Sports Med 1996;24:810-8.
2. Matheson GO, Clement DB, McKenzie DC, Taunton JE, Lloyd-Smith DR, MacIntyre JG. Stress fractures in athletes. A study of 320 cases. Am J Sports Med 1987;15:46-58.
3. Bennell KL, Brukner PD. Epidemiology and site specificity of stress fractures. Clin Sports Med 1997;16:179-96.
4. Snyder RA, Koester MC, Dunn WR. Epidemiology of stress fractures. Clin Sports Med 2006;25:37-52, viii.
5. Bennell KL, Malcolm SA, Thomas SA, Wark JD, Brukner PD. The incidence and distribution of stress fractures in competitive track and field athletes. A twelve-month prospective study. Am J Sports Med 1996;24:211-7.
6. Rauh MJ, Macera CA, Trone DW, Shaffer RA, Brodine SK. Epidemiology of stress fracture and lower-extremity overuse injury in female recruits. Med Sci Sports Exerc 2006;38:1571-7.
7. Boden BP, Osbahr DC. High-risk stress fractures: evaluation and treatment. J Am Acad Orthop Surg 2000;8:344-53.
8. Rencken ML, Chesnut CH III, Drinkwater BL. Bone density at multiple skeletal sites in amenorrheic athletes. J Am Med Assoc 1996;276:238-40.
9. Braam LA, Knapen MH, Geusens P, Brouns F, Vermeer C. Factors affecting bone loss in female endurance athletes: a two-year follow-up study. Am J Sports Med 2003;31:889-95.
10. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-37.
11. Romani WA, Gieck JH, Perrin DH, Saliba EN, Kahler DM. Mechanisms and management of stress fractures in physically active persons. J Athl Train 2002;37:306-14.
12. Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, et al. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 2003;196:2-8.
13. Kelly PJ, Bronk JT. Venous pressure and bone formation. Microvasc Res 1990;39:364-75.
14. Piekarski K, Munro M. Transport mechanism operating between blood supply and osteocytes in long bones. Nature 1977;269:80-2.
15. Arnett T. Regulation of bone cell function by acid-base balance. Proc Nutr Soc 2003;62:511-20.
16. Meghji S, Morrison MS, Henderson B, Arnett TR. pH dependence of bone resorption: mouse calvarial osteoclasts are activated by acidosis. Am J Physiol Endocrinol Metab 2001;280:E112-9.
17. Brandao-Burch A, Utting JC, Orriss IR, Arnett TR. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif Tissue Int 2005;77:167-74.
18. Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 2004;287:R502-16.
19. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 2000;11(Suppl 6):S2-17.
20. Stepan JJ. Prediction of bone loss in postmenopausal women. Osteoporos Int 2000;11(Suppl 6):S45-54.
21. Stegmann H, Kindermann W, Schnabel A. Lactate kinetics and individual anaerobic threshold. Int J Sports Med 1981;2:160-5.
22. Gabriel H, Kindermann W. The acute immune response to exercise: what does it mean? Int J Sports Med 1997;18(Suppl 1):S28-45.
23. -1 lactate. Int J Sports Med 1982;3:105-10.
24. Wetter TJ, St CC, Pegelow DF, Sonetti DA, Dempsey JA. Effects of exhaustive endurance exercise on pulmonary gas exchange and airway function in women. J Appl Physiol 2001;91:847-58.
25. Ratel S, Duche P, Hennegrave A, Van PE, Bedu M. Acidbase balance during repeated cycling sprints in boys and men. J Appl Physiol 2002;92:479-85.
26. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Vaananen HK. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 2001;47:597-600.
27. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000;113:377-81.
28. Vaaraniemi J, Halleen JM, Kaarlonen K, Ylipahkala H, Alatalo SL, Andersson G, et al. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res 2004;19:1432-40.
29. Halleen JM, Ranta R. Tartrate-resistant acid phosphatase as a serum marker of bone resorption. Am Clin Lab 2001;20:29-30.
30. Delmas PD, Hardy P, Garnero P, Dain M. Monitoring individual response to hormone replacement therapy with bone markers. Bone 2000;26:553-60.
31. Garnero P, Delmas PD. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am 1998;27:303-23.
32. Seibel MJ. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 2000;11(Suppl 6):S18-29.
33. Rosalki SB. Biochemical markers of bone turnover. Int J Clin Pract 1998;52:255-6.
34. Miller PD, Baran DT, Bilezikian JP, Greenspan SL, Lindsay R, Riggs BL, et al. Practical clinical application of biochemical markers of bone turnover: consensus of an expert panel. J Clin Densitom 1999;2:323-42.
35. Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, et al. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 1999;75:22-35.
36. Stein GS, Lian JB. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993;14:424-42.
37. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-30.
38. Lian JB, Stein GS. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992;3:269-305.
39. Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, et al. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 2003;88:394-401.
40. Maimoun L, Simar D, Malatesta D, Caillaud C, Peruchon E, Couret I, et al. Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects. Br J Sports Med 2005;39:497-502.
41. Wallace JD, Cuneo RC, Lundberg PA, Rosen T, Jorgensen JO, Longobardi S, et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 2000;85:124-33.
42. Brahm H, Piehl-Aulin K, Ljunghall S. Biochemical markers of bone metabolism during distance running in healthy, regularly exercising men and women. Scand J Med Sci Sports 1996;6:26-30.
43. Ebeling PR. Potential candidates for bone turnover markers-N-telopeptide cross-links of type I collagen. In: Eastell R, Baumann M, Hoyle NR, Wieczorek L, editors. Bone markers - biochemical and clinical perspectives. London: Martin Dunitz, 2001:27-38.
44. Kristoffersson A, Hultdin J, Holmlund I, Thorsen K, Lorentzon R. Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism. Int J Sports Med 1995;16:145-9.
45. Tosun A, Bolukbasi N, Cingi E, Beyazova M, Unlu M. Acute effects of a single session of aerobic exercise with or without weight-lifting on bone turnover in healthy young women. Mod Rheumatol 2006;16:300-4.
46. Langberg H, Skovgaard D, Asp S, Kjaer M. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif Tissue Int 2000;67:41-4.
47. Thorsen K, Kristoffersson A, Hultdin J, Lorentzon R. Effects of moderate endurance exercise on calcium, parathyroid hormone, and markers of bone metabolism in young women. Calcif Tissue Int 1997;60:16-20.
48. Woitge HW, Friedmann B, Suttner S, Farahmand I, Muller M, Schmidt-Gayk H, et al. Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res 1998;13:1797-804.
49. Karlsson KM, Karlsson C, Ahlborg HG, Valdimarsson O, Ljunghall S, Obrant KJ. Bone turnover responses to changed physical activity. Calcif Tissue Int 2003;72:675-80.
50. Karlsson KM, Karlsson C, Ahlborg HG, Valdimarsson O, Ljunghall S. The duration of exercise as a regulator of bone turnover. Calcif Tissue Int 2003;73:350-5.
51. Vesper HW, Demers LM, Eastell R, Garnero P, Kleerekoper M, Robins SP, et al. Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. Clin Chem 2002;48:220-35.
52. Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 2000;11(Suppl 6):S30-44.
53. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-8.
54. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 2000;27:283-6.
55. Garnero P, Delmas PD. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 2004;4:50-63.
56. Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 2002;13:523-6.
57. van Daele PL, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JP, et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. Br Med J 1996;312:482-3.
58. Ross PD. Predicting bone loss and fracture risk with biochemical markers: a review. J Clin Densitom 1999;2:285-94.